Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Eμ-MiR-155 transgenic mice

Blood

Volumn 114, Issue 7, 2009, Pages 1374-1382

  Costinean, Stefan ^a   Sandhu, Sukhinder K ^a   Pedersen, Irene M ^b   Tili, Esmerina ^a   Trotta, Rossana ^a   Perrotti, Danilo ^a   Ciarlariello, David ^a   Neviani, Paolo ^a   Harb, Jason ^a   Kauffman, Lauren Rachel ^a   Shidham, Aaditya ^a   Croce, Carlo Maria ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; INTERLEUKIN 6; MICRORNA; MIR 155; PROTEIN TYROSINE PHOSPHATASE SHP; SRC HOMOLOGY 2 DOMAIN CONTAINING INOSITOL 5 PHOSPHATASE; UNCLASSIFIED DRUG; INOSITOL 1,4,5 TRISPHOSPHATE 5 PHOSPHATASE; INOSITOL-1,4,5-TRISPHOSPHATE 5-PHOSPHATASE; MIRN155 MICRORNA, MOUSE; PHOSPHATASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; ANIMAL; B CELL LYMPHOMA; BIOSYNTHESIS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PRE B LYMPHOCYTE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; INTERLEUKIN-6; LYMPHOMA, B-CELL; MICE; MICE, TRANSGENIC; MICRORNAS; PHOSPHORIC MONOESTER HYDROLASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; SIGNAL TRANSDUCTION;

EID: 70349331525     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-220814     Document Type: Article

References (34)

1. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-866.
2. Calin GA, Ferracin A, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2006;353:1793-1801.
3. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257-2261. (Pubitemid 43271657)
4. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99:15524-15529. (Pubitemid 35403967)
5. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065-7070. (Pubitemid 41161233)
6. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828-833. (Pubitemid 40839734)
7. Eis PS, TamW, Sun L, et al. Accumulation of miR-155 and BIC RNAin human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102:3627-3632.
8. Kluiver J, Poppema S, de Jong D, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005;207:243-249. (Pubitemid 41404155)
9. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E[μυ]-miR-155 transgenic mice. Proc Natl Acad Sci U S A. 2006;103:7024-7029.
10. Nakamura K, Malykhin A, Coggeshall KM. The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcγ receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors. Blood. 2002;100:3374-3382. (Pubitemid 35217090)
11. -/- mice. J Exp Med. 2000;191:781-794.
12. Liu Q, Oliveira-dos-Santos AJ, Mariathasan S, et al. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med. 1998;188:1333-1342. (Pubitemid 28478021)
13. Nakajima T, Kinoshita S, Sasagawa T, et al. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA. 1993;90:2207-2211. (Pubitemid 23078595)
14. Trautwein C, Caelles C, van der Geer P, et al. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature. 1993;364:544-547. (Pubitemid 23273102)
15. Cooper C, Johnson D, Roman C, Avitahl N, Tucker P, Calame K. The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro. J Immunol. 1992;149:3225-3231.
16. Natsuka S, Akira S, Nishio Y, et al. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood. 1992;79:460-466.
17. Scott LM, Civin CI, Rorth P, Friedman AD. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood. 1992;80:1725-1735.
18. Screpanti I, Romani L, Musiani P, et al. Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice [Errata published in EMBO J. 1995;14:3596]. EMBO J. 1995;14:1932-1941.
19. Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316:604-608. (Pubitemid 46683147)
20. dim NK-cells provides a molecular basis for distinct functional responses to monokine co-stimulation. Blood. 2005;105:3011-3018.
21. Guerzoni C, Bardini M, Mariani SA, et al. Inducible activation of C/EBPβ, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells. Blood. 2006;107:4080-4089. (Pubitemid 43726817)
22. Vigorito E, Perks KL, Abreu-Goodger C, et al. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007;27:847-859. (Pubitemid 350258623)
23. T method. Nat Protoc. 2008;3:1101-1108.
24. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20.
25. Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92-105.
26. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol Cell. 2007;27:91-105. (Pubitemid 46991392)
27. Nakamura K, Kouro T, Kincade PW, et al. Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow. J Exp Med. 2004;199:243-254. (Pubitemid 38129704)
28. -/- mice: a novel model of myelodysplasia. Blood. 2004;103:4503-4510.
29. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A. 2009;106:7113-7118.
30. Pedersen IM, Otero DC, Kao E, et al. Onco-Mir-155 targets SHIP to regulate TNF-dependent B-cell lymphoma growth. Blood. 2008;112:604.
31. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 1990;86:592-599.
32. Screpanti I, Musiani P, Bellavia D, et al. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBPβ- deficient mice. J Exp Med. 1996;184:1561-1566. (Pubitemid 26354714)
33. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med. 2008;205:585-594.
34. Yin Q, McBride J, Fewell C, et al. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol. 2008;82:5295-5306. (Pubitemid 351705237)